Table 2. 13C Enrichment of cerebral amino acids from [U-13C6]glucose and [2-13C]acetate in different brain regions.
Brain Regions | Treatment Groups | 13C Enrichment (%) | ||||||
Glu4 | GABA2 | Gln4 | Glu3 | GABA3 | Glu3/Glu4 | GABA3/GABA2 | ||
Cortex | Control (n = 6) | 29.8±1.2 | 17.5±0.5 | 23.5±1.5 | 10.6±0.8 | 9.0±0.5 | 0.35±0.01 | 0.51±0.02 |
Nic (0.5 mg, n = 6) | 31.0±1.0 | 20.7±0.7** | 24.2±1.5 | 13.1±0.5 | 11.0±0.5 | 0.42±0.01** | 0.53±0.01 | |
Nic (2.0 mg, n = 6) | 34.8±1.0** | 22.1±0.6** | 27.7±1.6 | 14.9±0.7** | 12.2±0.5** | 0.43±0.01** | 0.55±0.02 | |
Subcortex | Control (n = 6) | 30.5±1.3 | 16.6±0.8 | 27.2±1.3 | 10.8±0.8 | 8.0±0.5 | 0.35±0.01 | 0.48±0.01 |
Nic (0.5 mg, n = 6) | 31.5±0.9 | 18.5±0.4 | 26.6±1.7 | 13.3±0.4* | 9.5±0.2* | 0.42±0.01** | 0.51±0.01 | |
Nic (2.0 mg, n = 6) | 35.8±1.2* | 20.5±0.8** | 33.2±1.8* | 15.4±0.5** | 10.8±0.5** | 0.43±0.01** | 0.53±0.01* | |
Cerebellum | Control (n = 6) | 27.3±1.1 | 20.9±1.1 | 22.7±1.5 | 9.2±0.7 | 10.3±1.0 | 0.34±0.01 | 0.49±0.02 |
Nic (0.5 mg, n = 6) | 29.4±1.0 | 24.3±0.8* | 23.1±1.3 | 12.0±0.5* | 14.2±0.9* | 0.41±0.01** | 0.58±0.02* | |
Nic (2.0 mg, n = 6) | 32.5±1.0** | 26.5±1.2** | 28.0±1.3* | 12.8±0.6** | 15.1±0.7** | 0.39±0.01** | 0.57±0.01** | |
Olfactory Bulb | Control (n = 6) | 36.6±1.5 | 13.9±0.5 | 28.7±1.8 | 14.9±1.0 | 6.5±0.4 | 0.41±0.02 | 0.46±0.01 |
Nic (0.5 mg, n = 6) | 36.1±1.9 | 14.8±0.5 | 26.9±1.9 | 16.3±0.8 | 8.4±0.4* | 0.45±0.01* | 0.54±0.02** | |
Nic (2.0 mg, n = 6) | 42.0±3.1 | 17.5±0.8** | 34.4±2.1 | 19.7±1.4* | 9.1±0.5** | 0.47±0.01** | 0.52±0.01** |
Percent 13C enrichment was measured in brain tissue extract using 1H-[13C]-NMR spectroscopy. Values represent mean±SEM.
p<0.05,
p<0.01 indicate significance of differences when compared to respective control.